一文了解头皮银屑病和脂溢性皮炎的皮肤镜鉴别

2021-09-17 医路坦克 MedSci原创

银屑病和脂溢性皮炎是相对常见的炎症性皮肤病,具体表现为红斑脱屑。这两种疾病有共同的临床病理特征,但皮肤镜检查时有一些明显的区别。

      银屑病和脂溢性皮炎是相对常见的炎症性皮肤病,具体表现为红斑脱屑。这两种疾病有共同的临床病理特征,但仔细检查时有一些明显的区别。银屑病通常表现为头皮、躯干和四肢上有厚厚的银白色斑块,特别是在四肢的伸肌表面。

      脂溢性皮炎的特征是皮肤上红色、剥落和油腻的区域,最常见的是头皮、鼻唇皱褶、耳朵、眉毛和胸部。有助于区分这两种疾病的另一个特征是额部发际线受累,这在银屑病中比脂溢性皮炎更常见。当这两种情况都局限在头皮上,而不累及其他皮肤部位时,皮肤活检可能有助于诊断。

     皮肤镜是评估色素性皮损的一种有价值的工具,它极大地提高了几乎所有色素性皮肤肿瘤的临床诊断。皮肤镜对无色素性皮损的评估也是有用的;皮肤镜检查显示了皮肤血管的独特形态特征。一项回顾性观察研究表明头皮银屑病最显著的皮肤镜特征是红点和红球、扭曲的红环和肾小球血管。相反,脂溢性皮炎的特征是树枝状血管和不典型的红色血管,没有红点和小球。脂溢性皮炎中也经常观察到缺乏任何特殊血管模式的无特征区。皮肤镜下发现的红线和其他血管图案被认为不能用于鉴别,因为这些在两种疾病中都是不常见的特征。虽然在两种疾病中都有常见的鳞片,但皮肤镜观察到的鳞片出现的频率和特征没有显著差异。

     皮肤镜下血管系统的特征性特征对诊断头皮银屑病很重要的三个有价值的血管特征,即红点和红球、扭曲的红环和肾小球血管。此外,该研究确定了三种血管类型,即树枝状血管、不典型红色血管和无特征区,它们与脂溢性皮炎密切相关。一些报告描述了银屑病的特殊皮肤镜特征,红色小球被认为是银屑病的关键诊断标准。研究中发现头皮银屑病最显著的皮肤镜特征是红点和球形(87%)。扭曲的红环(53%)和肾小球血管(65%)也有助于鉴别诊断。然而,脂溢性皮炎的特征是树枝状血管(49%)和不典型的红色血管(71%),并且没有红点和红球。在这两种疾病(牛皮癣47%;脂溢性皮炎71%)中,通常观察到不典型的红血管,但在脂溢性皮炎中这一特征的出现频率在统计学上显著更高。

     红点和红球代表细长的真皮乳头内扭曲和扩张的血管,是银屑病的特征性组织学特征。脂溢性皮炎的树枝状血管和不典型的红色血管显示轻度增生的网脊毛细血管明显扩张。脂溢性皮炎时,血管通过乳头状丛水平增殖并伴有血管周围炎症。

图1.(A)银屑病中的红点和红球(用黄色箭头表示)和扭曲的红环(用黑色箭头表示);(B)脂溢性皮炎中的树枝状血管(用黄色箭头表示)和不典型的红色血管(用黑色箭头表示)。

图2.图2皮肤镜类型和基本组织学特征的图示。银屑病患者真皮乳头内血管扭曲扩张,表现为红点、红球(a,红色箭头代表直角观)、肾小球血管(b,红色箭头代表直角观)和扭曲的红环(c:黄色箭头代表切线观)。脂溢性皮炎的分支血管(D)和不典型的红色血管(E)为轻度增生的网脊内的扩张性乳头下神经丛(蓝色箭头)。

  文献来源:Kim GW,  Jung HJ,  Ko HC,Dermoscopy can be useful in differentiating scalp psoriasis from seborrhoeic dermatitis.Br J Dermatol 2011 Mar;164(3)

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2037383, encodeId=d643203e38363, content=<a href='/topic/show?id=b7438430568' target=_blank style='color:#2F92EE;'>#脂溢性皮炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84305, encryptionId=b7438430568, topicName=脂溢性皮炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sat Oct 09 04:48:55 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080457, encodeId=6cbc108045e5d, content=图文并茂 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62935704829, createdName=ms9000000262856055, createdTime=Wed Dec 15 22:16:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763881, encodeId=69291e63881e5, content=<a href='/topic/show?id=517e84304da' target=_blank style='color:#2F92EE;'>#脂溢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84304, encryptionId=517e84304da, topicName=脂溢性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3cd37589120, createdName=ms3830150583600765, createdTime=Wed Dec 29 07:48:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486657, encodeId=69be148665eb0, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Sun Sep 19 02:48:55 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052400, encodeId=c25f105240004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Fri Sep 17 20:53:01 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2037383, encodeId=d643203e38363, content=<a href='/topic/show?id=b7438430568' target=_blank style='color:#2F92EE;'>#脂溢性皮炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84305, encryptionId=b7438430568, topicName=脂溢性皮炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sat Oct 09 04:48:55 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080457, encodeId=6cbc108045e5d, content=图文并茂 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62935704829, createdName=ms9000000262856055, createdTime=Wed Dec 15 22:16:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763881, encodeId=69291e63881e5, content=<a href='/topic/show?id=517e84304da' target=_blank style='color:#2F92EE;'>#脂溢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84304, encryptionId=517e84304da, topicName=脂溢性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3cd37589120, createdName=ms3830150583600765, createdTime=Wed Dec 29 07:48:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486657, encodeId=69be148665eb0, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Sun Sep 19 02:48:55 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052400, encodeId=c25f105240004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Fri Sep 17 20:53:01 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2021-12-15 ms9000000262856055

    图文并茂 学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2037383, encodeId=d643203e38363, content=<a href='/topic/show?id=b7438430568' target=_blank style='color:#2F92EE;'>#脂溢性皮炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84305, encryptionId=b7438430568, topicName=脂溢性皮炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sat Oct 09 04:48:55 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080457, encodeId=6cbc108045e5d, content=图文并茂 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62935704829, createdName=ms9000000262856055, createdTime=Wed Dec 15 22:16:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763881, encodeId=69291e63881e5, content=<a href='/topic/show?id=517e84304da' target=_blank style='color:#2F92EE;'>#脂溢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84304, encryptionId=517e84304da, topicName=脂溢性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3cd37589120, createdName=ms3830150583600765, createdTime=Wed Dec 29 07:48:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486657, encodeId=69be148665eb0, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Sun Sep 19 02:48:55 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052400, encodeId=c25f105240004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Fri Sep 17 20:53:01 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2037383, encodeId=d643203e38363, content=<a href='/topic/show?id=b7438430568' target=_blank style='color:#2F92EE;'>#脂溢性皮炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84305, encryptionId=b7438430568, topicName=脂溢性皮炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sat Oct 09 04:48:55 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080457, encodeId=6cbc108045e5d, content=图文并茂 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62935704829, createdName=ms9000000262856055, createdTime=Wed Dec 15 22:16:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763881, encodeId=69291e63881e5, content=<a href='/topic/show?id=517e84304da' target=_blank style='color:#2F92EE;'>#脂溢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84304, encryptionId=517e84304da, topicName=脂溢性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3cd37589120, createdName=ms3830150583600765, createdTime=Wed Dec 29 07:48:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486657, encodeId=69be148665eb0, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Sun Sep 19 02:48:55 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052400, encodeId=c25f105240004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Fri Sep 17 20:53:01 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2037383, encodeId=d643203e38363, content=<a href='/topic/show?id=b7438430568' target=_blank style='color:#2F92EE;'>#脂溢性皮炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84305, encryptionId=b7438430568, topicName=脂溢性皮炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Sat Oct 09 04:48:55 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080457, encodeId=6cbc108045e5d, content=图文并茂 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62935704829, createdName=ms9000000262856055, createdTime=Wed Dec 15 22:16:26 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763881, encodeId=69291e63881e5, content=<a href='/topic/show?id=517e84304da' target=_blank style='color:#2F92EE;'>#脂溢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84304, encryptionId=517e84304da, topicName=脂溢性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3cd37589120, createdName=ms3830150583600765, createdTime=Wed Dec 29 07:48:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486657, encodeId=69be148665eb0, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Sun Sep 19 02:48:55 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052400, encodeId=c25f105240004, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8212476654, createdName=1244c0ebm28暂无昵称, createdTime=Fri Sep 17 20:53:01 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2021-09-17 1244c0ebm28暂无昵称

    学习学习

    0

相关资讯

JAAD:窄谱紫外线 B 不同增量剂量方案对银屑病III-V 型皮肤治疗效果的比较

银屑病的首选治疗方法之一是窄谱紫外线 B (NB-UVB) 光疗。尽管 NB-UVB 被广泛使用,但关于合适的起始剂量和剂量增量的不同指南之间并不统一。

JEADV:替曲吉珠单抗 ( tildrakizumab )对中度至重度银屑病患者第28周停药后复发时间的研究

替曲吉珠单抗(Tildrakizumab) 是一种特异性单克隆抗体,靶向白细胞介素 (IL)-23 的 p19 亚基,已被批准用于治疗斑块状银屑病,已显示出长期有效性及安全性。

BJD:瑞莎珠单抗vs司库奇尤单抗在中度至重度斑块状银屑病患者中的疗效和安全性

Risankizumab(瑞莎珠单抗)和Suckinumab(司库奇尤单抗)分别抑制白细胞介素(IL)-23和IL-17A,对中重度斑块型银屑病成人患者有效,但给药方案不同。

JAAD:Ixekizumab 的长期疗效和安全性

Ixekizumab 是一种有效的中度至重度斑块状银屑病治疗方法,具有良好的安全性特征。ixekizumab 疗法适用于斑块状银屑病患者的长期治疗。

BJD:司库奇尤单抗治疗中重度掌跖银屑病的持续疗效观察

Suckinumab已经在几种牛皮癣症状上显示出持续的有效性和安全性,包括指甲、头皮、手掌、足底和银屑病关节炎。

BJD:司库奇尤单抗每周两次与每周四次给药对斑块型银屑病患者的疗效分析

银屑病是一种慢性炎症,在其长期治疗中实现和维持最佳反应的治疗策略至关重要。